1. Home
  2. YDESW vs VRXAW Comparison

YDESW vs VRXAW Comparison

Compare YDESW & VRXAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo YD Bio Limited Warrants

YDESW

YD Bio Limited Warrants

HOLD

Current Price

$0.41

Market Cap

0.0

Sector

N/A

ML Signal

HOLD

Logo Veraxa Biotech AG Warrants

VRXAW

Veraxa Biotech AG Warrants

N/A

Current Price

$0.10

Market Cap

0.0

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
YDESW
VRXAW
Founded
N/A
N/A
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
2024
2025

Fundamental Metrics

Financial Performance
Metric
YDESW
VRXAW
Price
$0.41
$0.10
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
15.7K
8.5K
Earning Date
N/A
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.19
$0.07
52 Week High
$2.85
$0.23

Technical Indicators

Market Signals
Indicator
YDESW
VRXAW
Relative Strength Index (RSI) 58.71 47.04
Support Level $0.37 $0.09
Resistance Level $0.58 $0.12
Average True Range (ATR) 0.06 0.01
MACD 0.01 0.00
Stochastic Oscillator 79.91 57.89

Price Performance

Historical Comparison
YDESW
VRXAW

About YDESW YD Bio Limited Warrants

YD Bio Ltd is a biotechnology company focused on regulated diagnostics, life science clinical services and healthcare product commercialization. Its operations include DNA methylation-based oncology testing programs in the United States under an LDT framework with CLIA-certified and CAP-accredited laboratory partners. The Company also provides life science distribution and clinical trial supply chain services, including procurement, logistics coordination and compliance-focused support for clinical development programs. It maintains ocular health product commercialization operations in the United States and consumer healthcare distribution activities in Asia. The Company operates in the United States and Taiwan, with Taiwan generating maximum revenue.

About VRXAW Veraxa Biotech AG Warrants

Veraxa Biotech Holding AG focus on antibody therapies in medicine. The Company is an oncology-focused biotechnology Company with a clinical program in acute myeloid leukemia and two proprietary platform technologies that enable the development of new generations of antibody drug conjugates (ADC's) and T cell engagers. The Company operates in one reportable segment, focused on the research and development of products for the aging population.

Share on Social Networks: